See what we’re reading this week at Global Biodefense on topics including the GSK malaria vaccine, involuntary quarantine lawsuit, the threat of Leishmaniasis, plague origins and more…
New Jersey governor facing lawsuit from nurse quarantined during Ebola scare (NPR)
Does the GSK malaria vaccine change things? (Tracking Zebra)
USDA tech makes detecting food toxins 100 times cheaper (FLC Newslink)
Leading malaria vaccine gets mixed reviews (NY Times)
Modular solutions for compounding pharmacies & biosafety facilities (DomPrep)
STEM interns get real-world experience in NHRC’s virtual reality lab (Armed with Science)
Why do so many people with the flu still show up for work? (CityLab)
States could be sanctioned for public health failings: WHO boss (Reuters)
Mystery deaths in Sierra Leone spread fear of Ebola relapses (Reuters)
U.S., ROK Marines test CBRN response during gas attack (U.S. Marine Corps)
Pandora Report 10.23.2015 (GMU Biodefense)
Leishmaniasis: The little-known, disfiguring disease that’s coming our way (NatGeo)
Fabrication of gold nanoparticles/graphene-PDDA nanohybrids for biodetection (NanoExpress)
Milwaukee VA Medical Center zaps germs with robots (Veterans Affairs)
US flu activity up a bit but still low, CDC says (CIDRAP)
Potentially deadly staph infections are still a risk for thousands of babies (Time)
Drug-resistant malaria can infect African mosquitoes (BBC News)
In ancient DNA, evidence of plague much earlier than previously known (NY Times)
New online tool helps analysts understand terrorist networks (HS Today)
UK and China team up on superbug research (Medical Research Council)
Mini DNA sequencer tests true (Phys.org)
USAMRIID strengthens immune-system research (Frederick News Post)
Bronze Age plague wasn’t spread by fleas (Science)
The 1.6 billion business of flu (CNBC)
